REPORT: FDA recalls another blood pressure drug for possible cancer risk
As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by USATODAY.COM:
The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer.
Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). The substance is a probable human carcinogen, according to the International Agency for Research on Cancer.
The article goes on to state the following:
Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. The contaminated medication was not distributed before Oct. 8.
To get more information about this article, please visit USATODAY.COM. To weigh in, leave a comment below.
DML News offered you the above information as part of our ongoing effort to educate and inform people around the world. You can obtain additional information by visiting USATODAY.COM
Trending on DML News
- REPORT: New details emerge on judge who upheld subpoenas on Trump’s bank records
- REPORT: Calif. Senate passes humongous spending plan that would expand benefits to people in U.S. illegally
- BREAKING: Lone Republican blocks House passage of disaster relief bill
- VIDEO: Lindsey Graham predicts Dems’ reaction to declassification of documents on Trump campaign surveillance
- REPORT: House Intelligence enjoys breakthrough with Justice Department
- REPORT: Trump, Pelosi wage Twitter war over ‘stammer’ video
- REPORT: Meteorologist fact-checks Ocasio-Cortez after her bizarre claim about tornado
- REPORT: Suspected illegal immigrant accused of impregnating 11-year-old girl [VIDEO]
- VIDEO: Trump responds to Theresa May’s resignation announcement
- REPORT: Twitter permanently bans two famous Trump antagonists